Legato Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Legato Capital Management LLC
- $761 Million
- Q3 2024
A detailed history of Legato Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 4,096 shares of REGN stock, worth $3.12 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
4,096
Previous 4,394
6.78%
Holding current value
$3.12 Million
Previous $4.62 Million
6.78%
% of portfolio
0.57%
Previous 0.65%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,533Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.44 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.71 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.74 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.28 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $81.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...